Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study

BACKGROUND: In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), selecting an antithrombotic regimen requires balancing risks of ischemic cardiac events, stroke, and bleeding. METHODS: We studied 467 patients with AF undergoing PCI in the time period from De...

Descripción completa

Detalles Bibliográficos
Autores principales: Valle, Felipe H., Goodman, Shaun G., Tan, Mary, Ha, Andrew, Mansour, Samer, Welsh, Robert C., Yan, Andrew T., Bainey, Kevin R., Rinfret, Stephane, Potter, Brian J., Khan, Razi, Simkus, Gerald, Natarajan, Madhu K., Schwalm, J.D., Daneault, Benoit, Eisenberg, Mark J., Abunassar, Joseph, Har, Bryan, Gregoire, Jean, Tanguay, Jean-Francois, Overgaard, Christopher B., Dery, Jean-Pierre, De Larochelliere, Robert, Paradis, Jean-Michel, Madan, Mina, Elbarouni, Basem, So, Derek Y.F., Quraishi, Ata-Ur-Rehman, Bagai, Akshay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712598/
https://www.ncbi.nlm.nih.gov/pubmed/34993453
http://dx.doi.org/10.1016/j.cjco.2021.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712598/
https://www.ncbi.nlm.nih.gov/pubmed/34993453
http://dx.doi.org/10.1016/j.cjco.2021.07.003

Ejemplares similares